Header Logo

Connection

ELIAS JOSEPH JABBOUR to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about TOR Serine-Threonine Kinases.
ELIAS JOSEPH JABBOUR
Connection Strength
0.020
TOR Serine-Threonine Kinases
  1. A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Cancer Res. 2015 Jun 15; 21(12):2704-14.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.